Literature DB >> 31556664

Concurrent and lagged associations of prescription opioid use with pain and negative affect in the daily lives of chronic pain patients.

Ryan W Carpenter1, Sean P Lane2, Stephen Bruehl3, Timothy J Trull4.   

Abstract

OBJECTIVE: Prescribed opioids for chronic pain management contribute significantly to the opioid crisis. There is a need to understand the real-world benefits that, despite risks, lead chronic pain patients to persist in opioid use. Negative reinforcement models of addiction posit that individuals use substances to reduce aversive states but have seldom been applied to prescribed opioids. Using ecological momentary assessment, we examined reciprocal associations between opioid use and physical pain, for which opioids are prescribed, and negative affect (NA), for which they are not.
METHOD: Chronic low back pain patients on long-term opioid therapy (n = 34) without significant past-year opioid misuse reported multiple times daily via smartphone over 2 weeks (nobservations = 2,285). We hypothesized that pain and NA would be positively associated with subsequent opioid use, and that use would be negatively associated with subsequent pain and NA.
RESULTS: Time-lagged multilevel models indicated that participants were more likely to use opioids and in larger doses following elevated pain and NA. There was also an interaction of concurrent pain and NA on opioid dose. In turn, participants reported reduced pain and NA following larger doses. Additionally, individuals at high risk for opioid misuse, compared with low risk, took larger doses following pain, but also experienced smaller subsequent pain and NA reductions.
CONCLUSIONS: Opioid use was bidirectionally associated with pain and NA. Findings fit negative reinforcement models associated with risk of developing opioid use disorder. Educating patients and providers about negative reinforcement may help reduce opioid use and opioid-associated risks. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31556664      PMCID: PMC6764518          DOI: 10.1037/ccp0000402

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  11 in total

Review 1.  A systematic review of engagement reporting in remote measurement studies for health symptom tracking.

Authors:  Katie M White; Charlotte Williamson; Nicol Bergou; Carolin Oetzmann; Valeria de Angel; Faith Matcham; Claire Henderson; Matthew Hotopf
Journal:  NPJ Digit Med       Date:  2022-06-29

2.  A Preliminary Investigation of the Underlying Mechanism Associating Daily Sleep Continuity Disturbance and Prescription Opioid Use Among Individuals With Sickle Cell Disease.

Authors:  Chung Jung Mun; Patrick H Finan; Michael T Smith; C Patrick Carroll; Joshua M Smyth; Sophie M Lanzkron; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Ann Behav Med       Date:  2021-06-02

Review 3.  Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.

Authors:  Rachel V Aaron; Patrick H Finan; Stephen T Wegener; Francis J Keefe; Mark A Lumley
Journal:  Am Psychol       Date:  2020-09

4.  Real-time associations between young adults' momentary pain and prescription opioid misuse intentions in daily life.

Authors:  Lauren M Papp; Chrystyna D Kouros; John J Curtin
Journal:  Am Psychol       Date:  2020-09

Review 5.  The role of affect in chronic pain: A systematic review of within-person symptom dynamics.

Authors:  Madelyn R Frumkin; Thomas L Rodebaugh
Journal:  J Psychosom Res       Date:  2021-05-24       Impact factor: 3.006

6.  Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy.

Authors:  Anna Parisi; Hannah Louise Landicho; Justin Hudak; Siri Leknes; Brett Froeliger; Eric L Garland
Journal:  Drug Alcohol Depend       Date:  2022-02-24       Impact factor: 4.852

7.  Leftover opioids following adult surgical procedures: a systematic review and meta-analysis.

Authors:  Lori Schirle; Amanda L Stone; Matthew C Morris; Sarah S Osmundson; Philip D Walker; Mary S Dietrich; Stephen Bruehl
Journal:  Syst Rev       Date:  2020-06-11

Review 8.  Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction.

Authors:  Caroline B Pantazis; Luis A Gonzalez; Brendan J Tunstall; Stephanie A Carmack; George F Koob; Leandro F Vendruscolo
Journal:  Sci Adv       Date:  2021-04-07       Impact factor: 14.136

Review 9.  Cognitive-Affective Transdiagnostic Factors Associated With Vulnerability to Alcohol and Prescription Opioid Use in the Context of Pain.

Authors:  Emily L Zale; Jessica M Powers; Joseph W Ditre
Journal:  Alcohol Res       Date:  2021-07-15

10.  Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management.

Authors:  Jumi Hayaki; Micah T Conti; Genie L Bailey; Debra S Herman; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.